Cerity Partners
KRRO icon

Cerity Partners’s Korro Bio KRRO Stock Holding History

Cerity Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$95K – 725
2021
Q1 		$95K Hold
200
– – ﹤0.01% 682
2020
Q4 		$353K Hold
200
– – 0.01% 481
2020
Q3 		$192K Hold
200
– – 0.01% 469
2020
Q2 		$233K Buy
+200
New +$181K 0.01% 392

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Cerity Partners's KRRO Position: Q2 2021 in Review

Cerity Partners sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 200 shares — an estimated $95K sold.

Cerity Partners first reported a position in KRRO in Q2 2020 and held it in 4 quarters. The position peaked at $353K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

  • Cerity Partners reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
  • Cerity Partners sold 200 Korro Bio shares in Q2 2021, an estimated $95K.
  • Cerity Partners first reported a position in Korro Bio in Q2 2020 and held it in 4 quarters.
  • Cerity Partners's Korro Bio position peaked at $353K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Cerity Partners's 13F filing for Q2 2021, filed 11 Aug 2021.